{"nct_id":"NCT02978482","title":"A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2016-12-01","start_date_type":"ACTUAL","primary_completion_date":"2018-01-28","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}